1. Home
  2. SNY vs NTES Comparison

SNY vs NTES Comparison

Compare SNY & NTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanofi ADS

SNY

Sanofi ADS

N/A

Current Price

$46.64

Market Cap

95.7B

Sector

Health Care

ML Signal

N/A

Logo NetEase Inc.

NTES

NetEase Inc.

N/A

Current Price

$99.96

Market Cap

77.8B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SNY
NTES
Founded
1994
1997
Country
France
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
95.7B
77.8B
IPO Year
2001
2002

Fundamental Metrics

Financial Performance
Metric
SNY
NTES
Price
$46.64
$99.96
Analyst Decision
Buy
Strong Buy
Analyst Count
11
32
Target Price
$54.92
★ $155.79
AVG Volume (30 Days)
★ 4.2M
927.5K
Earning Date
10-30-2026
11-19-2026
Dividend Yield
★ 5.25%
2.78%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.97
$3.17
Revenue Next Year
$6.77
$8.59
P/E Ratio
★ $6.14
$79.88
Revenue Growth
N/A
N/A
52 Week Low
$39.07
$104.63
52 Week High
$50.61
$149.11

Technical Indicators

Market Signals
Indicator
SNY
NTES
Relative Strength Index (RSI) 57.70 25.09
Support Level $45.95 N/A
Resistance Level $48.57 $120.60
Average True Range (ATR) 0.86 2.82
MACD -0.20 -2.21
Stochastic Oscillator 40.49 3.43

Price Performance

Historical Comparison
SNY
NTES

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About NTES NetEase Inc.

Founded in the late 1990s as an internet portal, NetEase has evolved into China's second-largest online gaming company. Its early success was anchored by the massively multiplayer online role-playing game Fantasy Westward Journey, which laid the foundation for a durable franchise strategy. Over the past decade, the company has expanded its portfolio with successful titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which continue to maintain sizable and engaged player bases.In addition to its in-house development capabilities, NetEase partners with global IP holders such as Microsoft and Marvel to develop and publish titles based on established franchises, including World of Warcraft, Diablo Immortal, and Marvel Rivals, further strengthening its global presence.

Share on Social Networks: